A three month double‐blind study of doxazosin as treatment for benign prostatic bladder outlet obstruction

Abstract

Doxazosin was well-tolerated and produced both urodynamic and symptomatic improvement in men with BPH, thereby providing a satisfactory alternative to existing drugs with the additional benefit of once daily dosage.